|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/19 | |
| A61K 31/404 | |||
| A61P 35/00 |
| (11) | Number of the document | 2134322 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08732162.6 |
| Date of filing the European patent application | 2008-03-13 | |
| (97) | Date of publication of the European application | 2009-12-23 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/056912 |
| Date | 2008-03-13 |
| (87) | Number | WO 2008/112934 |
| Date | 2008-09-18 |
| (30) | Number | Date | Country code |
| 894610 P | 2007-03-13 | US |
| (72) |
LENAZ, Luigi, US
CHAWLA, Shanta, US
BEER, Mario, US
|
| (73) |
Spectrum Pharmaceuticals, Inc.,
157 Technology Drive, Irvine, CA 92618,
US
|
| (54) | INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER |
| INTRAVESICAL APAZIQUONE ADMINISTRATION FOLLOWING TRANSURETHRAL RESECTION FOR TREATING BLADDER CANCER |